Weighted Average Number of Shares Outstanding, Basic of Roivant Sciences Ltd. from Q2 2021 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Roivant Sciences Ltd. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and change rate from Q2 2021 to Q3 2025.
  • Roivant Sciences Ltd. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 681M shares, a 7.41% decline year-over-year.
  • Roivant Sciences Ltd. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 725M shares, a 7.39% decline from 2023.
  • Roivant Sciences Ltd. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 783M shares, a 9.89% increase from 2022.
  • Roivant Sciences Ltd. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 713M shares, a 6.43% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Roivant Sciences Ltd. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 681M -54.5M -7.41% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025
Q2 2025 680M -55.5M -7.55% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025
Q1 2025 725M -57.9M -7.39% 01 Jan 2025 31 Mar 2025 10-K 29 May 2025
Q4 2024 723M -77.9M -9.73% 01 Oct 2024 31 Dec 2024 10-Q 10 Feb 2025
Q3 2024 735M -34.8M -4.51% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025
Q2 2024 736M -23.5M -3.09% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025
Q1 2024 783M +70.5M +9.89% 01 Jan 2024 31 Mar 2024 10-K 29 May 2025
Q4 2023 801M +87.3M +12.2% 01 Oct 2023 31 Dec 2023 10-Q 10 Feb 2025
Q3 2023 770M +70.3M +10.1% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 759M +63.4M +9.11% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024
Q1 2023 713M +43M +6.43% 01 Jan 2023 31 Mar 2023 10-K 29 May 2025
Q4 2022 713M +26.7M +3.89% 01 Oct 2022 31 Dec 2022 10-Q 13 Feb 2024
Q3 2022 700M +49.7M +7.64% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023
Q2 2022 696M +46M +7.08% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 670M 01 Jan 2022 31 Mar 2022 10-K 28 Jun 2023
Q4 2021 687M 01 Oct 2021 31 Dec 2021 10-Q 13 Feb 2023
Q3 2021 650M 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 650M 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022

Roivant Sciences Ltd. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 725M -57.9M -7.39% 01 Apr 2024 31 Mar 2025 10-K 29 May 2025
2023 783M +70.5M +9.89% 01 Apr 2023 31 Mar 2024 10-K 29 May 2025
2022 713M +43M +6.43% 01 Apr 2022 31 Mar 2023 10-K 29 May 2025
2021 670M 01 Apr 2021 31 Mar 2022 10-K 28 Jun 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.